These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10881278)

  • 1. The effect of apoE on dementia is not through atherosclerosis: the Rotterdam study.
    Knittweis JW; McMullen WA
    Neurology; 2000 Jun; 54(12):2356-8. PubMed ID: 10881278
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study.
    Slooter AJ; Cruts M; Ott A; Bots ML; Witteman JC; Hofman A; Van Broeckhoven C; Breteler MM; van Duijn CM
    Neurology; 1999 Oct; 53(7):1593-5. PubMed ID: 10534277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.
    Hofman A; Ott A; Breteler MM; Bots ML; Slooter AJ; van Harskamp F; van Duijn CN; Van Broeckhoven C; Grobbee DE
    Lancet; 1997 Jan; 349(9046):151-4. PubMed ID: 9111537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and the Risk of Dementia: The Rotterdam Study.
    Licher S; de Bruijn RFAG; Wolters FJ; Zillikens MC; Ikram MA; Ikram MK
    J Alzheimers Dis; 2017; 60(3):989-997. PubMed ID: 28984598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
    de Bruijn RF; Janssen JA; Brugts MP; van Duijn CM; Hofman A; Koudstaal PJ; Ikram MA
    J Alzheimers Dis; 2014; 42(1):137-42. PubMed ID: 24820016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.
    Davignon J; Bouthillier D; Nestruck AC; Sing CF
    Trans Am Clin Climatol Assoc; 1988; 99():100-10. PubMed ID: 3503432
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.
    Kashyap VS; Santamarina-Fojo S; Brown DR; Parrott CL; Applebaum-Bowden D; Meyn S; Talley G; Paigen B; Maeda N; Brewer HB
    J Clin Invest; 1995 Sep; 96(3):1612-20. PubMed ID: 7657831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of serum cortisol with cognitive function and dementia: the Rotterdam Study.
    Schrijvers EM; Direk N; Koudstaal PJ; Kirschbaum C; Hofman A; Tiemeier H; Breteler MM
    J Alzheimers Dis; 2011; 25(4):671-7. PubMed ID: 21483093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein e genotype.
    Lehtimäki T; Dastidar P; Jokela H; Koivula T; Lehtinen S; Ehnholm C; Punnonen R
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4147-53. PubMed ID: 12213863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
    Tynkkynen J; Hernesniemi JA; Laatikainen T; Havulinna AS; Salo P; Blankenberg S; Zeller T; Salomaa V
    J Neurol; 2017 Mar; 264(3):503-511. PubMed ID: 28039523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study.
    Bonarek M; Barberger-Gateau P; Letenneur L; Deschamps V; Iron A; Dubroca B; Dartigues JF
    Neuroepidemiology; 2000; 19(3):141-8. PubMed ID: 10705232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.
    Lehtimäki T; Porkka K; Viikari J; Ehnholm C; Akerblom HK; Nikkari T
    Pediatrics; 1994 Oct; 94(4 Pt 1):489-93. PubMed ID: 7936857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype and lipid and lipoprotein levels in dementia.
    Wehr H; Parnowski T; Puzyński S; Bednarska-Makaruk M; Bisko M; Kotapka-Minc S; Rodo M; Wołkowska M
    Dement Geriatr Cogn Disord; 2000; 11(2):70-3. PubMed ID: 10705163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.
    Patel S; Thelander EM; Hernandez M; Montenegro J; Hassing H; Burton C; Mundt S; Hermanowski-Vosatka A; Wright SD; Chao YS; Detmers PA
    Biochem Biophys Res Commun; 2001 Aug; 286(1):164-70. PubMed ID: 11485323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
    Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.
    Sullivan PM; Mezdour H; Quarfordt SH; Maeda N
    J Clin Invest; 1998 Jul; 102(1):130-5. PubMed ID: 9649566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.
    Solomon A; Kåreholt I; Ngandu T; Winblad B; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
    Neurology; 2007 Mar; 68(10):751-6. PubMed ID: 17339582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.